DJ Inovio Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. $(INO)$ sank 0.69% to $10.74 Friday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 0.96% to 15,973.17 and Dow Jones Industrial Average falling 0.49% to 38,714.77.
This was the stock's fourth consecutive day of losses.
Inovio Pharmaceuticals Inc. closed $2.83 below its 52-week high ($13.56), which the company reached on March 17th.
The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson $(JNJ)$ fell 0.65% to $158.18, Statera Biopharma Inc. (STAB) remained unchanged, and Pfizer Inc. $(PFE)$ fell 0.68% to $27.94.
Trading volume (311,780) remained 264,128 below its 50-day average volume of 575,908.
Data source: Dow Jones Market Data, FactSet. Data compiled March 15, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
March 15, 2024 17:31 ET (21:31 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments